(Q77928561)
Statements
Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen (English)
R Schirmbeck
K Melber
scientific article published on 01 July 1999
No description defined